awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q26993238-144CF948-FCD2-4E9F-B584-78E02D88EC60
Q26993238-144CF948-FCD2-4E9F-B584-78E02D88EC60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26993238-144CF948-FCD2-4E9F-B584-78E02D88EC60
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy
P2860
Q26993238-144CF948-FCD2-4E9F-B584-78E02D88EC60
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26993238-144CF948-FCD2-4E9F-B584-78E02D88EC60
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
12c5f50374fd0176a012dd4f82dbd5c3edde682e
P2860
Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial.